Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
InBev
InBev Receives DOJ Request for Additional Information Regarding Proposed Combination With Anheuser-Busch
September 7th, 2008
InBev (Euronext: INB) announced that it has received a request for additional information, commonly referred to as a Second Request, from the U.S. Department of Justice (DOJ) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to the previously announced combination with Anheuser-Busch. InBev intends to respond expeditiously to the Second Request and to work toward a prompt closing of the transaction. In addition to the expiration of the waiting period under the HSR Act, completion of the transaction remains subject to InBev and Anheuser-Busch shareholder approvals, regulatory review in certain other jurisdictions and customary closing...
Source: Pharma Investments, Ventures & Law Weekly (2008-09-07)
|
